Celadon Pharmaceuticals (LSE:CEL) Days Payable : 5,007.05 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Days Payable?

Celadon Pharmaceuticals's average Accounts Payable for the six months ended in Jun. 2023 was €1.07 Mil. Celadon Pharmaceuticals's Cost of Goods Sold for the six months ended in Jun. 2023 was €0.04 Mil. Hence, Celadon Pharmaceuticals's Days Payable for the six months ended in Jun. 2023 was 5,007.05.

The historical rank and industry rank for Celadon Pharmaceuticals's Days Payable or its related term are showing as below:

LSE:CEL' s Days Payable Range Over the Past 10 Years
Min: 2175.96 Med: 4803.16 Max: 7430.36
Current: 3696.15

During the past 4 years, Celadon Pharmaceuticals's highest Days Payable was 7430.36. The lowest was 2175.96. And the median was 4803.16.

LSE:CEL's Days Payable is ranked better than
97.85% of 977 companies
in the Drug Manufacturers industry
Industry Median: 87.27 vs LSE:CEL: 3696.15

Celadon Pharmaceuticals's Days Payable increased from Jun. 2022 (4,843.01) to Jun. 2023 (5,007.05). It may suggest that Celadon Pharmaceuticals delayed paying its suppliers.

Celadon Pharmaceuticals Days Payable Historical Data

The historical data trend for Celadon Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Days Payable Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Payable

7,430.36

2,175.96

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Payable	Get a 7-Day Free Trial			-	638.75	4,843.01	2,374.87	5,007.05

Competitive Comparison of Celadon Pharmaceuticals's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Days Payable falls into.

Celadon Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Celadon Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0	+	0.62)	/	1 )	/	0.104	*	365
=	0.62					/	0.104	*	365
=	2,175.96

Celadon Pharmaceuticals's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.62	+	1.52)	/	2 )	/	0.039	*	365 / 2
=	1.07					/	0.039	*	365 / 2
=	5,007.05

Celadon Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines